Intramyocardial immunomodulation with human CD16<sup>+</sup> monocytes to treat myocardial infarction in pig: a blind randomized preclinical trial.

Front Cardiovasc Med · 2024 · PMC11335517 · PMID 39171324

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

not quite significantp = 0.06so close (0.05 < p ≤ 0.1)

Tissue levels of IL-6 appeared to be higher in the hCD16 + Ms group although this was not quite significant ( p = 0.06).

also in 653 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.